We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Orexigen, Duke, Eisai Strike Foreign IP Deal

Law360 (September 19, 2007, 12:00 AM EDT) -- Orexigen Therapeutics Inc., Duke University and Eisai Co Ltd. on Wednesday agreed to a settlement that resolves all foreign aspects of a lawsuit related to the use of zonisamide to treat obesity, which had been filed by Orexigen and Duke against Eisai and was settled in the United States at the end of 2006.

Eisai, Duke and Orexigen have released each other from claims outside the United States that relate to the lawsuit, or certain foreign Duke or Eisai patents that may issue from applications claiming...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.